Join us
Support our cause
INTL directors
SCIENTIFIC DRUG-FREE PREVENTION AND TREATMENT OF DISEASES
A Non-Profit Medical Research Organization with international scientists
from many countries working to serve humanity
- 501 (c) (3) Pending -
www. apri-us.orgple text.
info@apri-us.orgple text.
They are the inspiration for us
to carry out
This Mission for Humanity
They have devoted their entire life to fight for humanity, healthcare, for the poor, for peace and prosperity for countries around the world. Their life, their legacy and role model are the inspiration for all of us to live up t0. We like to dedicate our work and our lifelong admiration to President Carter and First Lady Rosalynn.
We learn the beauty of life and of love BECAUSE OF YOU.
We love you PRESIDENT AND FIRST LADY CARTER
Distinguished scholars we may seek their advise as needed to achieve medical values and safety of our research and formula.
These are donors or investors who dictate the POLICIES, DIRECTION AND QUALITY of SERVICE to humanity. They also assist in the expansion to other COUNTRIES.
Directors are responsible for the operations and conduct of all research and support projects.
They are professionals delegated to ensure of the legal and financial integrity or compliance of our work to applicable laws and regulations of where our work is located
These are respected academic, scientific institutions that will conduct in vivo and in vitro tests; Also listed are hospitals that conduct clinical research or validation studies.
They are located outside of the US for cost and productivity but all medical records are accessible to any authorized entities.
Advisorory Panels are to review, propose and approve the medical and scientific principles
behind the treatment formula within each of the disease treatment remedies. Advisory panels do not determine the efficacy of the treatment itself and not responsible for the outcome of the treatment
| Molecular Biology | Pharmacology - Pharmacy | Medicine - Pathology | Botany, |
|---|---|---|---|
| Albert-Ludwigs
University of Freiburg, Pharmaceutical Biology and Biotechnology, Stefan-Meier Str, Breisgau, Germany; |
Ito Haru
Okayama University, Pharmaceutical Sciences, 1 – 1-1 Tsushimanaka, Kita-ku, 7008530 Okayama, Japan |
Li C
Huazhong Agricultural University, College of Food Science and Technology, Wuhan, China |
F Afifi-Yazar and R Abu Dahab
Faculty of Pharmacy and Pharmaceutical science, University of Jordan, Jordan |
| Fouquet Laguerre
1ISM-UMR 5255, University of Bordeaux Cours de la Liberation, 33405 Talence, France; |
C. Agyare , M Lechtenberg
Institute for Pharmaceutical Biology and Phytochemistry, University of Muenster, Germany |
Pieters L
Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium |
A Rodrigues , Salmen Espindola
Laboratorio de Farmacognosia, Faculdade de CiÞncias da Saude, Universidade de Brasilia, Brasilia, Brazil |
| L Saaby , S Christensen
Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark |
S. Van Vuuren
Dept of Pharmacy andPharmacology, University of Witwatersrand, Johannesburg, South Africa |
Yang N
Agricultural Biotechnology Research Center, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan Taipei, Taiwan |
Sheela. D, Uthayakumari
Head of the Department of Botany Mary’s College, Thoothukudi. Tamilnadu, India |
| C Gonçalves, P Pereira. M Gama.
Institute for Biotechnology and Bioengineering, Centre for Biological Engineering, University, Campus de Gualtar 4710-057, Braga, Portugal |
Polyxeni Alexiou & Vassilis Demopoulos, Dept of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, Greece | Prof. Wang Ben
Office of Translational Medicine School of Medicine University of Zhejiang, China |
| ASIA | europe and us | MID EAST, AUSTRALIA |
|---|---|---|
| Kathryn Tan
Professor in Medicine, Head of the Division of Endocrinology and Metabolism at the University of Hong Kong. Her main research interest include lipid disorders and lipoprotein metabolism, and the role of dyslipidaemia in the pathogenesis of vascular and diabetic complications. She is currently serving on the Executive Board of the Asian Association for the Study of Diabetes. |
Stephen Franks Imperial College London, UK Professor of reproductive endocrinology, Faculty of Medicine. He has clinical and laboratory-based programmes of research in the field of normal and disordered function of the hypothalamic-pituitary-ovarian axis and polycystic ovary syndrome (PCOS). His research interest is on the interaction between genetic and environmental factors in aetiology of the syndrome. |
Eduardo Arzt, University of Buenos Aires, Argentina Professor, Member, National Research Council of Argentina, Visiting Professor at the Max Planck Institute of Psychiatry in Munich, Germany, External Scientific Member of the Max Planck Society and Director of the BioMedicine Institute of Buenos Aires His interest is in the molecular biology of pituitary tumors and hormone production. |
| Kok Onn Lee, National University of Singapore Professor and Consultant Endocrinologist at the National University Hospital in Singapore. His clinical interests are in Pituitary and Gonadal Endocrinology, his research interests include the GH/IGF/IGFBP axis in fertility, and stem cells and gene therapy in Diabetes. |
Alicja Hubalewska-Dydejczyk Jagiellonian University, Medical College in Cracow, Poland. Professor/Chair of the Dept of Endocrinology, specialist in internal medicine, endocrinology and nuclear medicine, major research interest is thyreology, with special concerns in thyroid dysfunction in pregnancy and in optimization of the iodine prophylaxis. | |
| Poonam Sharma, Department of Biomedical Sciences, Bundelkhand University, Jhansi-284128 UP India. Renown Doctor and Professor of Bioscience, leading author of phytomedicine in the treatment of Diabetes II
|
Paolo Governa,Department of Physical Sciences, Earth and Environment, University of Siena, \Via Laterina 8, 53100 Siena, Italy. Italy's leading expert in phytomedicinal therapy of diabetes | |
| PENDING | PENDING |
These distinguished individuals will serve as POLICY MAKERS, INTERNATIONAL ORGANIZERS AND FINANCIAL SUPPORTERS OF OUR ORGANIZATION
INTERIM REPRESENTATIVES OF THE INDIVIDUAL NATION TO SERVE UNTIL A PERMANENT DIRECTOR IS SELECTED/APPOINTED BY THE FOUNDING MEMBERS TO A 3-YEAR TERM
These are Independent Directors responsible for the LEGAL/ETHICAL COMPLIANCE, FINANCIAL ACCOUNTABILITY, FUND-RAISING, DONORS, IT-E-COMMERCE to facilitate an effective operation of the entire organization
Mutual Support Organizations
| Medical/Health Organizations | International Health Organizations | Phyto or Scientific Organizations | Others |
|---|---|---|---|
|
|
|||
|
|
|||
